These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 22648863)

  • 1. Native-state solubility and transfer free energy as predictive tools for selecting excipients to include in protein formulation development studies.
    Banks DD; Latypov RF; Ketchem RR; Woodard J; Scavezze JL; Siska CC; Razinkov VI
    J Pharm Sci; 2012 Aug; 101(8):2720-32. PubMed ID: 22648863
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Formulation design and high-throughput excipient selection based on structural integrity and conformational stability of dilute and highly concentrated IgG1 monoclonal antibody solutions.
    Bhambhani A; Kissmann JM; Joshi SB; Volkin DB; Kashi RS; Middaugh CR
    J Pharm Sci; 2012 Mar; 101(3):1120-35. PubMed ID: 22147527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isotonic concentrations of excipients control the dimerization rate of a therapeutic immunoglobulin G1 antibody during refrigerated storage based on their rank order of native-state interaction.
    Banks DD; Cordia JF; Spasojevic V; Sun J; Franc S; Cho Y
    Protein Sci; 2018 Dec; 27(12):2073-2083. PubMed ID: 30267438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Excipients differentially influence the conformational stability and pretransition dynamics of two IgG1 monoclonal antibodies.
    Thakkar SV; Joshi SB; Jones ME; Sathish HA; Bishop SM; Volkin DB; Middaugh CR
    J Pharm Sci; 2012 Sep; 101(9):3062-77. PubMed ID: 22581714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studying Excipient Modulated Physical Stability and Viscosity of Monoclonal Antibody Formulations Using Small-Angle Scattering.
    Xu AY; Castellanos MM; Mattison K; Krueger S; Curtis JE
    Mol Pharm; 2019 Oct; 16(10):4319-4338. PubMed ID: 31487466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of cosolutes on the isomerization of aspartic acid residues and conformational stability in a monoclonal antibody.
    Wakankar AA; Liu J; Vandervelde D; Wang YJ; Shire SJ; Borchardt RT
    J Pharm Sci; 2007 Jul; 96(7):1708-18. PubMed ID: 17238195
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of temperature and osmolytes on competing degradation routes for an IgG1 antibody.
    Roberts CJ; Nesta DP; Kim N
    J Pharm Sci; 2013 Oct; 102(10):3556-66. PubMed ID: 23873602
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Local dynamics and their alteration by excipients modulate the global conformational stability of an lgG1 monoclonal antibody.
    Thakkar SV; Kim JH; Samra HS; Sathish HA; Bishop SM; Joshi SB; Volkin DB; Middaugh CR
    J Pharm Sci; 2012 Dec; 101(12):4444-57. PubMed ID: 23060088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of Electrostatic Mediated Antibody Liquid-Liquid Phase Separation by Charged and Noncharged Preferentially Excluded Excipients.
    Banks DD; Cordia JF
    Mol Pharm; 2021 Mar; 18(3):1285-1292. PubMed ID: 33555888
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utility of High Throughput Screening Techniques to Predict Stability of Monoclonal Antibody Formulations During Early Stage Development.
    Goldberg DS; Lewus RA; Esfandiary R; Farkas DC; Mody N; Day KJ; Mallik P; Tracka MB; Sealey SK; Samra HS
    J Pharm Sci; 2017 Aug; 106(8):1971-1977. PubMed ID: 28456733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of Excipient Effects on Reversible Self-Association, Backbone Flexibility, and Solution Properties of an IgG1 Monoclonal Antibody at High Concentrations: Part 1.
    Hu Y; Arora J; Joshi SB; Esfandiary R; Middaugh CR; Weis DD; Volkin DB
    J Pharm Sci; 2020 Jan; 109(1):340-352. PubMed ID: 31201906
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of a high-throughput screening procedure with PEG-induced precipitation to compare relative protein solubility during formulation development with IgG1 monoclonal antibodies.
    Gibson TJ; Mccarty K; Mcfadyen IJ; Cash E; Dalmonte P; Hinds KD; Dinerman AA; Alvarez JC; Volkin DB
    J Pharm Sci; 2011 Mar; 100(3):1009-21. PubMed ID: 21280052
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of ions on agitation- and temperature-induced aggregation reactions of antibodies.
    Fesinmeyer RM; Hogan S; Saluja A; Brych SR; Kras E; Narhi LO; Brems DN; Gokarn YR
    Pharm Res; 2009 Apr; 26(4):903-13. PubMed ID: 19104916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High throughput thermostability screening of monoclonal antibody formulations.
    He F; Hogan S; Latypov RF; Narhi LO; Razinkov VI
    J Pharm Sci; 2010 Apr; 99(4):1707-20. PubMed ID: 19780136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of pH and excipients on structure, dynamics, and long-term stability of a model IgG1 monoclonal antibody upon freeze-drying.
    Park J; Nagapudi K; Vergara C; Ramachander R; Laurence JS; Krishnan S
    Pharm Res; 2013 Apr; 30(4):968-84. PubMed ID: 23184227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viscosity-Lowering Effect of Amino Acids and Salts on Highly Concentrated Solutions of Two IgG1 Monoclonal Antibodies.
    Wang S; Zhang N; Hu T; Dai W; Feng X; Zhang X; Qian F
    Mol Pharm; 2015 Dec; 12(12):4478-87. PubMed ID: 26528726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of salts from the Hofmeister series on the conformational stability, aggregation propensity, and local flexibility of an IgG1 monoclonal antibody.
    Majumdar R; Manikwar P; Hickey JM; Samra HS; Sathish HA; Bishop SM; Middaugh CR; Volkin DB; Weis DD
    Biochemistry; 2013 May; 52(19):3376-89. PubMed ID: 23594236
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformational analysis of protein secondary structure during spray-drying of antibody/mannitol formulations.
    Schüle S; Friess W; Bechtold-Peters K; Garidel P
    Eur J Pharm Biopharm; 2007 Jan; 65(1):1-9. PubMed ID: 17034996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of arginine glutamate on the stability of monoclonal antibodies in solution.
    Kheddo P; Tracka M; Armer J; Dearman RJ; Uddin S; van der Walle CF; Golovanov AP
    Int J Pharm; 2014 Oct; 473(1-2):126-33. PubMed ID: 24992318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of high-throughput biophysical methods to identify stabilizing excipients for a model IgG2 monoclonal antibody: conformational stability and kinetic aggregation measurements.
    Cheng W; Joshi SB; He F; Brems DN; He B; Kerwin BA; Volkin DB; Middaugh CR
    J Pharm Sci; 2012 May; 101(5):1701-20. PubMed ID: 22323186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.